Physician profile
Steven Buchbinder
NPI 1134197759
$2,022.84
in general payments reported to CMS, 2019-2025
16 companies · $207 in 2025
The $207 reported for 2025 was less than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $692 · 2020: $191 · 2022: $198 · 2023: $249 · 2024: $485 · 2025: $207.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $941.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $941.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Solventum Corporation | $274.14 | 2024 | Prevena Restor Axioform, V.A.C. Veraflo Cleanse Choice, Activ.A.C. |
| Smith+Nephew, INC. | $195.41 | 2023-2025 | Stravix, Grafix, Grafix Pl |
| Stryker Corporation | $194.22 | 2019 | |
| Davol INC. | $191.05 | 2020 | |
| Zimvie INC. | $136.12 | 2023 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $125.00 | 2019 | |
| Paratek Pharmaceuticals, INC. | $124.98 | 2025 | Nuzyra |
| Osiris Therapeutics INC. | $121.57 | 2019 | |
| Next Science LLC | $118.39 | 2024 | Blastx, Xperience, Surgx |
| Organogenesis INC. | $115.51 | 2019 | |
| Abbvie INC. | $99.55 | 2022 | |
| Horizon Therapeutics Plc | $98.76 | 2022 | |
| Polaris Technology Solutions LLC | $92.30 | 2024 | |
| Kci USA, INC. | $91.15 | 2019 | |
| Osteomed LLC | $24.13 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $20.56 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Buchbinder listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.